DBPAP // Monolith NT.115 microscale thermophoresis (MA)

The Food and Drug Administration is forecasting a maintenance agreement for the Monolith NT.115 microscale thermophoresis instrument, covering the base year in FY23 under contract C-1235 and extending into option years including FY24 under contract C-1083. This instrument is critical for biological research and analysis within the agency’s Center for Biologics Evaluation and Research, requiring specialized ongoing support to ensure operational precision and regulatory compliance. The maintenance agreement will include comprehensive service coverage such as preventative maintenance, repairs, calibration, software updates, and technical support tailored to the unique demands of microscale thermophoresis technology. The contract opportunity is classified under NAICS code 811219, indicating it pertains to other commercial and industrial machinery and equipment repair and maintenance services. The point of contact for program-related inquiries is the Cber Acquisition Liaison, reachable via cberacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. The solicitation is published as a forecast on the HHS OSDBU portal with no set-aside designation, meaning it is open to all eligible vendors without restrictions based on business size or type. The anticipated contract action is focused on securing reliable, long-term technical support to sustain the functionality and data integrity of this high-precision instrument across federal research operations.